Submission of Annual Secretarial Compliance Report received from Practising Company Secretary - Ragini Chokshi & Co. for the period ended 31st March, 2025
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs & Organics Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations. The report was prepared by Practising Company Secretary Ragini Chokshi & Co. and signed on May 17, 2025. The company was found to be generally compliant with SEBI regulations, circulars, and Secretarial Standards during the review period. One minor issue was flagged: under SEBI's Insider Trading Regulations, the SDD (Structured Digital Database) software was installed but due compliance was not maintained initially, though the company has since made the required compliances from December 24, 2024 onward. Two prior-year non-compliance issues (late Cash Flow Statement submission and XBRL filing) had already been resolved, with the related fines waived by BSE and NSE in February 2024. No action has been taken against the company, its promoters, or directors by SEBI or stock exchanges.
This is a routine annual regulatory filing and does not indicate any material concern for shareholders. The company is largely in good compliance standing with SEBI norms, with only minor historical or remedied issues. No direct impact on stock price is expected.